ITEM METADATA RECORD
Title: Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds
Authors: Thorrez, Lieven
Shansky, Janet
Wang, Lin
Fast, Loren
Vandendriessche, Thierry
Chuah, Marinee
Mooney, David
Vandenburgh, Herman # ×
Issue Date: Jan-2008
Publisher: Elsevier sci ltd
Series Title: Biomaterials vol:29 issue:1 pages:75-84
Abstract: Skeletal muscle transplantation strategies for muscle repair or gene therapy involve either the injection of proliferating myoblasts followed by fusion with host myofibers or implantation of ex vivo differentiated myofibers; however, both implant procedures are associated with significant cell loss. Biodegradable porous, gas-foamed poly-lactide-co-glycolide (PLG) scaffolds have desirable characteristics for cell transfer and were used to study attachment, growth, differentiation and survival of human myogenic cells. Primary human myoblasts suspended in clinical grade extracellular matrixes (ECMs) and adhered to PLG scaffolds differentiated in vitro into high-density tropomyosin positive myofibers. An immunodeficient non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mouse implant model was used to study the transfer and in vivo survival of differentiated human myofibers on these scaffolds. Scaffold rigidity allowed the myofibers to be maintained under tension in vitro and following subcutaneous transplantation in vivo. Following implantation, myofiber density on the PLG scaffolds decreased linearly by 78% over a 4-week period. ECM composed of either Tisseel((R)) fibrin or Zyderm((R)) collagen type I did not significantly affect in vivo cell viability over the 4-week period. Varying PLG scaffold microsphere content (10-100%) also had little effect on cell survival in vivo. In contrast, when the residual NK cell population in the immunodeficient NOD/SCID mouse model was depleted with anti-asialo GM1 (ASGM1) antiscrum, in vivo cell survival significantly increased from 22% to 34% after 4 weeks. With further improvements in cell survival, PLG scaffolds may prove useful for the implantation of primary human myofibers in future clinical applications. (c) 2007 Elsevier Ltd. All rights reserved.
ISSN: 0142-9612
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Molecular and Vascular Biology
ESAT - STADIUS, Stadius Centre for Dynamical Systems, Signal Processing and Data Analytics
Biochemistry Section (Medicine) (-)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Thorrez et al. - 2008 - Biomaterials - Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds.pdf Published 1558KbAdobe PDFView/Open

 


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science